BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Countries North America

Insilico Medicine Launches PandaClaw To Advance AI Driven Drug Discovery And Target Identification

Insilico Medicine ("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced the launch of ...

March 25, 2026 | News

Innovent Advances Tigulixostat Into Phase 3 To Challenge Standard Gout Therapy

Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality med...

March 24, 2026 | News

ImmunityBio Secures Macau Approval For ANKTIVA In BCG Unresponsive Non Muscle Invasive Bladder Cancer

Macau SAR, China regulator grants approval for ANKTIVA® (nogapendekin alfa inbakicept-pmln) in patients with BCG-unresponsive NMIBC with CIS &plusm...

March 23, 2026 | News

Dizal Reports ZEGFROVY Achieves Superior Progression Free Survival In Phase 3 WU KONG28 Trial For EGFR Exon20ins NSCLC

Treatment with ZEGFROVY® resulted in statistically significant and clinically meaningful improvement in progression free survival (PFS) over pla...

March 23, 2026 | News

CellCarta And Biofidelity Expand Global Partnership With Exclusive Aspyre Lung Deployment In Clinical Trials

CellCarta and Biofidelity announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre® Lung in clinical trial settin...

March 20, 2026 | News

SK Pharmteco Commits 100 Million Dollars To Strengthen Viral Vector Capabilities And Multi Modality CDMO Strategy

SK pharmteco announced a significant funding commitment to support strategic initiatives within its viral vector business, while reaffirming its long-term ...

March 20, 2026 | News

Pace Life Sciences Advances Digital Laboratory Operations With Labguru Platform Integration

Cenevo’s Labguru platform is delivering a comprehensive solution to centralize documentation processes at Pace® Life Sciences, a U...

March 20, 2026 | News

Eccogene Enrols First Patient In Phase 2a MIST Trial Combining ECC4703 With Semaglutide

-Eccogene, a clinical-stage biopharmaceutical company developing next-generation oral small molecule therapeutics for chronic cardiometabolic and inflammat...

March 18, 2026 | News

Celltrion Expands US Immunology Portfolio With AVTOZMA Subcutaneous Tocilizumab Biosimilar

AVTOZMA® (tocilizumab-anoh) is among the first wave of tocilizumab biosimilars with both intravenous (IV) and subcutaneous (SC) formulations app...

March 17, 2026 | News

Unixell Biotech Secures US FDA IND Clearance For iPSC Derived Epilepsy Cell Therapy

Unixell Biotech achieved a significant milestone as UX-GIP001, its iPSC-derived allogeneic cell therapy targeting focal epilepsy, secured Investigational N...

March 16, 2026 | News

Biophytis And LynxKite Expand AI Drug Discovery Alliance To Advance Next Generation Longevity Therapies

Biophytis and LynxKite launch new modalities beyond MASSIVE: AI-driven drug discovery for next-generation longevity therapies This partnership will...

March 16, 2026 | News

Waters Corporation Launches ARES G3 Rheometer To Accelerate Materials Research And Testing

Reduces standard testing times by 80%.1 Delivers an industry-leading 25,000 data points per second, detecting transient material behaviors previously in...

March 11, 2026 | News

Insilico Medicine AI Discovered CKD Anemia Drug ISM4808 Enters Phase I Clinical Trial

Insilico Medicine (Insilico Medicine, HKEX: 03696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), announced th...

March 09, 2026 | News

Thermo Fisher Opens Cryo Electron Microscopy Drug Discovery Center In South San Francisco

Thermo Fisher Scientific, the world leader in serving science, today announced the opening of its Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center ...

March 06, 2026 | News

Stay Connected